技术服务

Services

发布日期:2025/3/23 4:00:39
上一篇:Plasma and urine complement activation products in light chain and heavy chain deposition disease 下一篇:Lipoamino Acid-Modified GnRH Analogs with Receptor-Mediated Antiproliferative Activity in Prostate and Ovarian Cancer Cells